Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Amyris Inc. AMRS

Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States. The company generates revenue from the sale of renewable products, licenses of and...

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:AMRS)

Fundamentals Snapshot (NDAQ:AMRS)

Opinion & Analysis (NDAQ:AMRS)

No current opinion is available.

Bullboard Posts (NDAQ:AMRS)

New SeekingAlpha Article:"Amyris:Surviving the Perfect Storm

New comprehensive and forward-looking article just published on SeekingAlpha https://seekingalpha.com/.../4484181-amyris-surviving......
jthottam - February 3, 2022

Answer to a Yahoo Question on AMRS Share Price

I thought this would be helpful for everyone but is in response to Jan R.'s question about "I need AMRS to reach $25 to become...
jthottam - December 22, 2021

Update from ImmunityBio (includes information on AMRS JV)

Update: Amyris (Ticker: AMRS)   The following press release today (December 20th, 2021) from ImmunityBio (Ticker...
jthottam - December 20, 2021

IDRI Contract with BARDA (potential opportunity for AMRS)

Update: Amyris (Ticker: AMRS)   The following was published by Infection Disease Research Institue ("IDRI"...
jthottam - December 18, 2021

Status Update on IBRX and AMRS

The following is a recent CNN video of an interview of the Chairman of ImmunityBio (Ticker: IBRX) Patrick Soon-Shiong who is in a joint...
jthottam - December 16, 2021

My thoughts on Q4 Revenue Forecast

UPDATE: Amyris (Ticker: AMRS)   My Q4 forecast estimates:   From the Q3 call, we know that AMRS...
jthottam - December 13, 2021